These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 19426124

  • 1. New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses.
    Arnold DM, Nazi I, Kelton JG.
    Expert Opin Investig Drugs; 2009 Jun; 18(6):805-19. PubMed ID: 19426124
    [Abstract] [Full Text] [Related]

  • 2. New options after first-line therapy for chronic immune thrombocytopenic purpura.
    Burzynski J.
    Am J Health Syst Pharm; 2009 Jan 15; 66(2 Suppl 2):S11-21. PubMed ID: 19139486
    [Abstract] [Full Text] [Related]

  • 3. Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura.
    Stasi R, Evangelista ML, Amadori S.
    Drugs; 2008 Jan 15; 68(7):901-12. PubMed ID: 18457458
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thrombopoietin Receptor Agonists in Children with Immune Thrombocytopenia: A New Therapeutic Era.
    Lassandro G, Palladino V, Vecchio GCD, Palmieri VV, Corallo PC, Faienza MF, Giordano P.
    Endocr Metab Immune Disord Drug Targets; 2021 Jan 15; 21(3):397-406. PubMed ID: 32473624
    [Abstract] [Full Text] [Related]

  • 8. Infection-related transient loss of response and other early side effects in chronic ITP during treatment with thrombopoietin mimetics.
    Meyer O, Salama A.
    Onkologie; 2011 Jan 15; 34(1-2):10-3. PubMed ID: 21346379
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia.
    Kuter DJ.
    Annu Rev Med; 2009 Jan 15; 60():193-206. PubMed ID: 19642221
    [Abstract] [Full Text] [Related]

  • 12. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura.
    Zeng Y, Duan X, Xu J, Ni X.
    Cochrane Database Syst Rev; 2011 Jul 06; 2011(7):CD008235. PubMed ID: 21735426
    [Abstract] [Full Text] [Related]

  • 13. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD, Herrington JD.
    Pharmacotherapy; 2010 Jul 06; 30(7):666-83. PubMed ID: 20575632
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.
    Kuter DJ, Macahilig C, Grotzinger KM, Poston SA, Wang PF, Dawson KL, Ward M.
    Int J Hematol; 2015 Mar 06; 101(3):255-63. PubMed ID: 25586660
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study.
    Neunert C, Despotovic J, Haley K, Lambert MP, Nottage K, Shimano K, Bennett C, Klaassen R, Stine K, Thompson A, Pastore Y, Brown T, Forbes PW, Grace RF, Pediatric ITP Consortium of North America (ICON).
    Pediatr Blood Cancer; 2016 Aug 06; 63(8):1407-13. PubMed ID: 27135461
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.
    Cooper N, Scully M, Percy C, Nicolson PLR, Lowe G, Bagot CN, Thachil J, Grech H, Nokes T, Hill QA, Bradbury C, Talks K, Dutt T, Evans G, Pavord S, Wexler S, Charania A, Collington SJ, Ervin A, Ramscar N, Provan D.
    Br J Haematol; 2024 Jun 06; 204(6):2442-2452. PubMed ID: 38429869
    [Abstract] [Full Text] [Related]

  • 20. The use of thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): a "real life" retrospective multicenter experience of the Rete Ematologica Pugliese (REP).
    Mazza P, Minoia C, Melpignano A, Polimeno G, Cascavilla N, Di Renzo N, Specchia G.
    Ann Hematol; 2016 Jan 06; 95(2):239-44. PubMed ID: 26596973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.